{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:19:57Z","timestamp":1791537597472,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaip.2018.10.042","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T12:07:43Z","timestamp":1541419663000},"page":"879-897.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Relationship Between Anaphylaxis and Use of Beta-Blockers and Angiotensin-Converting Enzyme Inhibitors: A Systematic Review and Meta-Analysis of Observational Studies"],"prefix":"10.1016","volume":"7","author":[{"given":"Miguel A.","family":"Tejedor-Alonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Farias-Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"P\u00e9rez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Grifol-Clar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Moro-Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rosado-Ingelmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.10.042_bib1","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"1507","article-title":"Heart failure: management","author":"Mehra","year":"2015"},{"key":"10.1016\/j.jaip.2018.10.042_bib2","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"1578","article-title":"Ischemic heart disease","author":"Antman","year":"2015"},{"key":"10.1016\/j.jaip.2018.10.042_bib3","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"1599","article-title":"ST-segment elevation myocardial infarction","author":"Antman","year":"2015"},{"key":"10.1016\/j.jaip.2018.10.042_bib4","first-page":"139","article-title":"Anaphylactic complications in patients treated with beta-blockers. Apropos of 14 cases","volume":"41","author":"Benitah","year":"1986","journal-title":"Therapie"},{"key":"10.1016\/j.jaip.2018.10.042_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-115-4-270","article-title":"Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma","volume":"115","author":"Lang","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2018.10.042_bib6","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/archinte.1993.00410170119012","article-title":"Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders","volume":"153","author":"Lang","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2018.10.042_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11882-008-0008-8","article-title":"Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?","volume":"8","author":"Lang","year":"2008","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2018.10.042_bib8","first-page":"351","article-title":"Drugs as risk factors of food anaphylaxis in adults: a case-control study","volume":"193","author":"Moneret-Vautrin","year":"2009","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.jaip.2018.10.042_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase\u2014a study of the European Academy of Allergology and Clinical Immunology Interest Group on insect venom hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/cea.12275","article-title":"Predictors of clinical effectiveness of Hymenoptera venom immunotherapy","volume":"44","author":"Rueff","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2018.10.042_bib11","first-page":"1341125","article-title":"Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals","author":"Clark","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anai.2016.02.014","article-title":"Safety and tolerability during build-up phase of a rush venom immunotherapy","volume":"116","author":"Bernkopf","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0091-6749(03)01940-7","article-title":"Life-threatening anaphylaxis to venom immunotherapy in a patient taking an angiotensin-converting enzyme inhibitor","volume":"112","author":"Ober","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib14","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0140-6736(92)93314-D","article-title":"Ace inhibitors and anaphylactoid reactions during venom immunotherapy","volume":"340","author":"Tunondelara","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2018.10.042_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1081-1206(10)60321-3","article-title":"Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy","volume":"101","author":"White","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.anai.2015.03.001","article-title":"Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective","volume":"114","author":"Stoevesandt","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcct.2015.02.003","article-title":"\u00df-Blocker premedication does not increase the frequency of allergic reactions from coronary CT angiography: results from the Advanced Cardiovascular Imaging Consortium","volume":"9","author":"Aggarwal","year":"2015","journal-title":"J\u00a0Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jaip.2018.10.042_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1152\/jappl.1978.44.3.455","article-title":"Distribution and pharmacological release of histamine in canine lung in\u00a0vivo","volume":"44","author":"Nisam","year":"1978","journal-title":"J\u00a0Appl Physiol Respir Environ Exerc Physiol"},{"key":"10.1016\/j.jaip.2018.10.042_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/cpt1971123559","article-title":"Correspondence. Propranolol","volume":"12","author":"Corbascio","year":"1971","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2018.10.042_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0091-6749(73)90091-2","article-title":"Effect of beta adrenergic stimulation and blockade on immediate hypersensitivity skin test reactions","volume":"52","author":"Shereff","year":"1973","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/all.12924","article-title":"Can we identify patients at risk of life-threatening allergic reactions to food?","volume":"71","author":"Turner","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.10.042_bib23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jaip.2017.04.033","article-title":"Are ACE inhibitors and beta-blockers dangerous in patients at risk for anaphylaxis?","volume":"5","author":"Coop","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.10.042_bib24","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2018.10.042_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2018.10.042_bib26","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/0140-6736(91)92967-7","article-title":"Anaphylactoid reactions, hemodialysis, and ace inhibitors","volume":"337","author":"Verresen","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2018.10.042_bib27","first-page":"S47","article-title":"Anaphylactoid reactions during hemodialysis","volume":"42","author":"Schaefer","year":"1994","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jaip.2018.10.042_bib28","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.jaci.2004.12.176","article-title":"Cardiopulmonary resuscitation (CPR) in patients with acure anaphylaxis taking beta blockers","volume":"115","author":"Alam","year":"2005","journal-title":"J Allergy Clin Immnol"},{"key":"10.1016\/j.jaip.2018.10.042_bib29","doi-asserted-by":"crossref","first-page":"1149.e5","DOI":"10.1016\/j.jaci.2013.06.015","article-title":"Anaphylaxis: clinical patterns, mediator release, and severity","volume":"132","author":"Brown","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib30","first-page":"230","article-title":"Clinical and immunological features and subsequent course of patients with severe insect sting anaphylaxis","volume":"83","author":"Lantner","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2013.01.011","article-title":"Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis","volume":"131","author":"Lee","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib32","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2004.11.012","article-title":"Use of beta-blockers during immunotherapy for Hymenoptera venom allergy","volume":"115","author":"Muller","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2012.03.024","article-title":"Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria\/angioedema","volume":"130","author":"Stoevesandt","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jaci.2007.12.003","article-title":"Factors predicting anaphylaxis to peanuts and tree nuts in\u00a0patients referred to a specialist center","volume":"121","author":"Summers","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib35","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0091-6749(87)90290-9","article-title":"Effects of beta-adrenergic and calcium antagonists on the development of anaphylactoid reactions from radiographic contrast media during cardiac angiography","volume":"80","author":"Greenberger","year":"1987","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.10.042_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0091-6749(05)80105-8","article-title":"Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections","volume":"86","author":"Hepner","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cea.12276","article-title":"Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase","volume":"44","author":"Stoevesandt","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2018.10.042_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jaip.2018.10.042_bib39","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2018.10.042_bib40","series-title":"Meta-Analysis in Stata: An Updated Collection from the State Journal","first-page":"29","article-title":"Metan: fixed- and random-effects meta-analysis","author":"Harris","year":"2016"},{"key":"10.1016\/j.jaip.2018.10.042_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trial","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jaip.2018.10.042_bib42","series-title":"Meta-Analysis in Stata: An Updated Collection from the State Journal","first-page":"66","article-title":"Tests for publication bias in meta-analysis","author":"Steichen","year":"2016"},{"key":"10.1016\/j.jaip.2018.10.042_bib43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib44","doi-asserted-by":"crossref","first-page":"AB20","DOI":"10.1016\/j.jaci.2013.12.097","article-title":"Factors associated with increased risk of anaphylaxis","volume":"133","author":"Riedel","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib45","first-page":"941","article-title":"Identification of risk factors for severe hypersensitivity reactions in general anaesthesia","volume":"36","author":"Schroeder","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2018.10.042_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect\u00a0estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2018.10.042_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2018.10.042_bib48","series-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]","first-page":"399","article-title":"Including non-randomized studies","author":"Reeves","year":"2011"},{"key":"10.1016\/j.jaip.2018.10.042_bib49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0091-6749(95)70123-0","article-title":"Gender risk for anaphylactoid reaction to radiographic contrast media","volume":"95","author":"Lang","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib50","first-page":"977","article-title":"Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis","volume":"113","author":"TenBrook","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib51","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/sim.3511","article-title":"Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells","volume":"28","author":"R\u00fccker","year":"2009","journal-title":"Statist Med"},{"key":"10.1016\/j.jaip.2018.10.042_bib52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2018.04.014","article-title":"Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2018.10.042_bib53","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/all.13380","article-title":"Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from The European Anaphylaxis Registry","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.10.042_bib54","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaip.2017.12.020","article-title":"Patients taking beta-blockers do not require increased doses of epinephrine for anaphylaxis","volume":"6","author":"White","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.10.042_bib55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2018.10.042_bib56","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcct.2015.02.003","article-title":"\u00df-blocker premedication does not increase the frequency of allergic reactions from coronary CT angiography: results from the Advanced Cardiovascular Imaging Consortium","volume":"9","author":"Aggarwal","year":"2015","journal-title":"J\u00a0Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jaip.2018.10.042_bib57","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.jaci.2004.12.176","article-title":"Cardiopulmonary resuscitation (CPR) in patients with acute anaphylaxis taking beta-blockers","volume":"115","author":"Alam","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib58","first-page":"139","article-title":"Anaphylactic complications in patients treated with beta-blockers. Apropos of 14 cases","volume":"41","author":"Benitah","year":"1986","journal-title":"Therapie"},{"key":"10.1016\/j.jaip.2018.10.042_bib59","doi-asserted-by":"crossref","first-page":"1149.e5","DOI":"10.1016\/j.jaci.2013.06.015","article-title":"Anaphylaxis: clinical patterns, mediator release, and severity","volume":"132","author":"Brown","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib60","first-page":"1341125","article-title":"Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals","author":"Clark","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib61","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/archinte.1993.00410170119012","article-title":"Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders","volume":"153","author":"Lang","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2018.10.042_bib62","first-page":"230","article-title":"Clinical and immunological features and subsequent course of patients with severe insect sting anaphylaxis","volume":"83","author":"Lantner","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib63","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2013.01.011","article-title":"Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis","volume":"131","author":"Lee","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0001-4079(19)32589-0","article-title":"Drugs as risk factors of food anaphylaxis in adults: a case-control study","volume":"193","author":"Moneret-Vautrin","year":"2009","journal-title":"Bulletin De L Academie Nationale De Medecine"},{"key":"10.1016\/j.jaip.2018.10.042_bib65","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2004.11.012","article-title":"Use of beta-blockers during immunotherapy for Hymenoptera venom allergy","volume":"115","author":"Muller","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib66","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib67","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase\u2014a study of the European Academy of Allergology and Clinical Immunology Interest Group on insect venom hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib68","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2012.03.024","article-title":"Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria\/angioedema","volume":"130","author":"Stoevesandt","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib69","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.anai.2015.03.001","article-title":"Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective","volume":"114","author":"Stoevesandt","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib70","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jaci.2007.12.003","article-title":"Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center","volume":"121","author":"Summers","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib71","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anai.2016.02.014","article-title":"Safety and tolerability during build-up phase of a rush venom immunotherapy","volume":"116","author":"Bernkopf","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib72","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0091-6749(87)90290-9","article-title":"Effects of beta-adrenergic and calcium antagonists on the development of anaphylactoid reactions from radiographic contrast media during cardiac angiography","volume":"80","author":"Greenberger","year":"1987","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2018.10.042_bib73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0091-6749(05)80105-8","article-title":"Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections","volume":"86","author":"Hepner","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2018.10.042_bib74","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/cea.12275","article-title":"Predictors of clinical effectiveness of Hymenoptera venom immunotherapy","volume":"44","author":"Rueff","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2018.10.042_bib75","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cea.12276","article-title":"Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase","volume":"44","author":"Stoevesandt","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2018.10.042_bib76","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1081-1206(10)60321-3","article-title":"Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy","volume":"101","author":"White","year":"2008","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981830713X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981830713X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:18:31Z","timestamp":1761974311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321981830713X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S221321981830713X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.10.042","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship Between Anaphylaxis and Use of Beta-Blockers and Angiotensin-Converting Enzyme Inhibitors: A Systematic Review and Meta-Analysis of Observational Studies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}